Xylem Inc has a consensus price target of $115.68, established from looking at the 76 latest analyst ratings. The last 3 analyst ratings were released from Oppenheimer, Citigroup, and Baird on April 18, 2024, April 8, 2024, and March 21, 2024. With an average price target of $143 between Oppenheimer, Citigroup, and Baird, there's an implied 10.31% upside for Xylem Inc from these 3 analyst ratings.
1calculated from analyst ratings published within the last 3 years
date | ticker | Buy Now | Company | Current price | Upside/Downside | Analyst Firm | Analyst & % Accurate | Price Target Change | Rating Change | Previous / Current Rating | Get Alert |
---|---|---|---|---|---|---|---|---|---|---|---|
04/18/2024 | XYL | Buy Now | Xylem | $129.64 | 9.53% | Oppenheimer | Bryan Blair | $133 → $142 | Maintains | Outperform | Get Alert |
04/08/2024 | XYL | Buy Now | Xylem | $129.64 | 7.22% | Citigroup | Andrew Kaplowitz | $126 → $139 | Maintains | Neutral | Get Alert |
03/21/2024 | XYL | Buy Now | Xylem | $129.64 | 14.16% | Baird | Michael Halloran | $141 → $148 | Maintains | Outperform | Get Alert |
03/12/2024 | XYL | Buy Now | Xylem | $129.64 | 15.71% | Exane BNP Paribas | Andrew Buscaglia | → $150 | Initiates | → Outperform | Get Alert |
02/07/2024 | XYL | Buy Now | Xylem | $129.64 | 15.71% | Stifel | Nathan Jones | $136 → $150 | Maintains | Buy | Get Alert |
02/07/2024 | XYL | Buy Now | Xylem | $129.64 | -2.81% | Citigroup | Andrew Kaplowitz | $122 → $126 | Maintains | Neutral | Get Alert |
02/07/2024 | XYL | Buy Now | Xylem | $129.64 | 11.85% | RBC Capital | Deane Dray | $140 → $145 | Maintains | Outperform | Get Alert |
01/04/2024 | XYL | Buy Now | Xylem | $129.64 | 7.99% | RBC Capital | Deane Dray | $120 → $140 | Maintains | Outperform | Get Alert |
12/19/2023 | XYL | Buy Now | Xylem | $129.64 | 4.91% | Stifel | Nathan Jones | $133 → $136 | Maintains | Buy | Get Alert |
12/13/2023 | XYL | Buy Now | Xylem | $129.64 | -2.04% | Wolfe Research | Brad Hewitt | → $127 | Initiates | → Outperform | Get Alert |
12/11/2023 | XYL | Buy Now | Xylem | $129.64 | -15.92% | Citigroup | Andrew Kaplowitz | $104 → $109 | Maintains | Neutral | Get Alert |
11/21/2023 | XYL | Buy Now | Xylem | $129.64 | -7.44% | Deutsche Bank | Andy Krill | $104 → $120 | Upgrade | Hold → Buy | Get Alert |
11/01/2023 | XYL | Buy Now | Xylem | $129.64 | -19.78% | Citigroup | Andrew Kaplowitz | $101 → $104 | Maintains | Neutral | Get Alert |
11/01/2023 | XYL | Buy Now | Xylem | $129.64 | -7.44% | RBC Capital | Deane Dray | $123 → $120 | Maintains | Outperform | Get Alert |
10/19/2023 | XYL | Buy Now | Xylem | $129.64 | -8.98% | Oppenheimer | Bryan Blair | → $118 | Upgrade | Perform → Outperform | Get Alert |
10/09/2023 | XYL | Buy Now | Xylem | $129.64 | -22.09% | Citigroup | Andrew Kaplowitz | $125 → $101 | Maintains | Neutral | Get Alert |
10/02/2023 | XYL | Buy Now | Xylem | $129.64 | -5.89% | Melius Research | Scott Davis | → $122 | Upgrade | Hold → Buy | Get Alert |
08/29/2023 | XYL | Buy Now | Xylem | $129.64 | — | Seaport Global | Scott Graham | — | Initiates | → Neutral | Get Alert |
08/03/2023 | XYL | Buy Now | Xylem | $129.64 | -0.49% | RBC Capital | Deane Dray | $133 → $129 | Maintains | Outperform | Get Alert |
The latest price target for Xylem (NYSE: XYL) was reported by Oppenheimer on April 18, 2024. The analyst firm set a price target for $142.00 expecting XYL to rise to within 12 months (a possible 7.98% upside). 24 analyst firms have reported ratings in the last year.
The latest analyst rating for Xylem (NYSE: XYL) was provided by Oppenheimer, and Xylem maintained their outperform rating.
The last upgrade for Xylem Inc happened on November 21, 2023 when Deutsche Bank raised their price target to $120. Deutsche Bank previously had a hold for Xylem Inc.
The last downgrade for Xylem Inc happened on January 4, 2023 when Raymond James changed their price target from N/A to N/A for Xylem Inc.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Xylem, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Xylem was filed on April 18, 2024 so you should expect the next rating to be made available sometime around April 18, 2025.
While ratings are subjective and will change, the latest Xylem (XYL) rating was a maintained with a price target of $133.00 to $142.00. The current price Xylem (XYL) is trading at is $131.50, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.